Schroeder, Andreas,Helwig, Christoph,Loos, Anja-Helena,Schueler, Armin,Falk, Martin,Butts, Charles,Shepherd, Frances A.
申请号：
AU2014267749
公开号：
AU2014267749A1
申请日:
2014.04.14
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The invention is directed to the treatment of lung cancer, preferably non-small cell lung cancer (NSCLC) by means of a combination therapy comprising concurrent chemo-radiotherapy followed by vaccination with a muc-1 lipopetide. The therapy elicits prolonged survival rates compared to a respective therapy including sequential chemo-radiotherapy.
